| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.065 | 0.1 |